Space Research Carries On

WASHINGTON—Smaller payloads, alternative boosters and suborbital flights are making it possible for space scientists to carry out their experiments in the aftermath of the explosion of the space shuttle Challenger one year ago this month. NASA's billion-dollar budget for space science survived relatively unscathed for the current year, and officials are hopeful that the same will be true for fiscal 1988. But flight time, not money, is the biggest immediate problem for scientists, acknowled

Written byJohn Rhea
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

NASA's billion-dollar budget for space science survived relatively unscathed for the current year, and officials are hopeful that the same will be true for fiscal 1988. But flight time, not money, is the biggest immediate problem for scientists, acknowledged John Holtz, assistant director of NASA's Astrophysics Division.

"We need these alternatives to support the PIs [principal investigators] due to the lack of flight opportunities in the wake of the down time and extensions in the [shuttle] manifest," Holtz said. The astronomy and physics programs received the majority of the funds for space science, $528 million in fiscal 1987, with planetary exploration receiving $374 million and the life sciences $70 million.

The space program relies heavily on the work of university-based researchers and their graduate students, who design many of the experiments and later help to analyze the data. In many cases, the projects serve as material for dissertations and theses. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies